Internal Medicine, Infectious Disease · Birmingham, AL
NPI
1659474435
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4704 Cahaba River Rd, Suite 101d
Birmingham, AL, 35243
Phone (205) 739-2335
Groups this clinician bills Medicare through
Medicare paid, 2024
$286K
31,519 services
Medicare patients, 2024
220
Average age 73
Drug cost, 2024
$704K
832 prescriptions
Company payments, 2025
$1,028
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William I Lapidus was code J0878 (injection, daptomycin, 1 mg), 23,600 times for 12 patients. In total William I Lapidus billed 31,519 services in 53 codes, and Medicare paid $286K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 23,600 | 12 | $0.05 | $1,062 |
| 99233 Hospital E&M - Subsequent | Facility | 263 | 116 | $82.76 | $22K |
| 99223 Hospital E&M - Initial | Facility | 115 | 107 | $117.37 | $13K |
| 96365 Intravenous Infusion, Hydration | Office | 99 | 34 | $42.15 | $4,172 |
| 99291 Critical Care E&M | Facility | 51 | 21 | $151.77 | $7,740 |
| 99215 Office E&M - Established | Office | 32 | 28 | $119.70 | $3,830 |
| 99232 Hospital E&M - Subsequent | Facility | 13 | 13 | $56.04 | $728 |
| 99231 Hospital E&M - Subsequent | Facility | 13 | 13 | $35.14 | $457 |
By year: 2022 $701K for 176,031 services; 2023 $481K for 63,085 services; 2024 $286K for 31,519 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 12 | $2.95 | $56.13 |
Medicare prescription drug claims, 2024
In 2024, the drug William I Lapidus prescribed most often to Medicare patients was Daptomycin, with 140 prescriptions and refills. In total William I Lapidus wrote 832 Medicare prescriptions that cost $704K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 140 | 140 | 35 | $61K |
| Ceftriaxone Ceftriaxone Sodium | 82 | 82 | 22 | $12K |
| Cefazolin Sodium Generic | 71 | 71 | 14 | $8,778 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 71 | 73 | Under 11 | $284K |
| Doxycycline Hyclate Generic | 60 | 74 | 24 | $1,232 |
| Ertapenem Ertapenem Sodium | 57 | 57 | 16 | $19K |
| Dovato Dolutegravir Sodium/Lamivudine | 48 | 50 | Under 11 | $151K |
| Cephalexin Generic | 30 | 38 | Under 11 | $378 |
| Tivicay Dolutegravir Sodium | 28 | 28 | Under 11 | $60K |
| Cefdinir Generic | 27 | 30 | 14 | $850 |
| Vancomycin Hcl Generic | 19 | 19 | Under 11 | $1,857 |
| Levofloxacin Generic | 19 | 22 | 14 | $271 |
| Lamivudine Generic | 17 | 17 | Under 11 | $1,639 |
| Descovy Emtricitabine/Tenofov Alafenam | 11 | 11 | Under 11 | $24K |
| Amoxicillin Generic | 11 | 17 | Under 11 | $54.45 |
Brand drugs: 176 claims; generic drugs: 656 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William I Lapidus $1,028 ($1,028 in general payments such as food, travel and fees) from 10 companies. The largest payer was Merck Sharp & Dohme LLC with $431.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 12 | $431 |
| Gilead Sciences, Inc. GILD | 14 | $256 |
| La Jolla Pharmaceutical Company | 4 | $88.97 |
| ViiV Healthcare Company GSK | 5 | $85.11 |
| Insmed, Inc. INSM | 2 | $64.44 |
| Cumberland Pharmaceuticals, Inc. CPIX | 2 | $37.25 |
| Astellas Pharma US Inc 4503.T | 1 | $19.19 |
| Paratek Pharmaceuticals, Inc. | 1 | $16.73 |
| Ferring Pharmaceuticals Inc. | 1 | $15.77 |
| Melinta Therapeutics, LLC | 1 | $13.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.